The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Prevalence of HPV Infection Among Females in the United States
Open accessAbstract
CONTEXT: Human papillomavirus (HPV) infection is estimated to be the most common sexually transmitted infection. Baseline population prevalence data for HPV infection in the United States before widespread availability of a prophylactic HPV vaccine would be useful. OBJECTIVE: To determine the prevalence of HPV among females in the United States. DESIGN, SETTING, AND PARTICIPANTS: The National Health and Nutrition Examination Survey (NHANES) uses a representative sample of the US noninstitutionalized civilian population. Females aged 14 to 59 years who were interviewed at home for NHANES 2003-2004 were examined in a mobile examination center and provided a self-collected vaginal swab specimen. Swabs were analyzed for HPV DNA by L1 consensus polymerase chain reaction followed by type-specific hybridization. Demographic and sexual behavior information was obtained from all participants. MAIN OUTCOME MEASURES: HPV prevalence by polymerase chain reaction. RESULTS: The overall HPV prevalence was 26.8% (95% confidence interval [CI], 23.3%-30.9%) among US females aged 14 to 59 years (n = 1921). HPV prevalence was 24.5% (95% CI, 19.6%-30.5%) among females aged 14 to 19 years, 44.8% (95% CI, 36.3%-55.3%) among women aged 20 to 24 years, 27.4% (95% CI, 21.9%-34.2%) among women aged 25 to 29 years, 27.5% (95% CI, 20.8%-36.4%) among women aged 30 to 39 years, 25.2% (95% CI, 19.7%-32.2%) among women aged 40 to 49 years, and 19.6% (95% CI, 14.3%-26.8%) among women aged 50 to 59 years. There was a statistically significant trend for increasing HPV prevalence with each year of age from 14 to 24 years (P<.001), followed by a gradual decline in prevalence through 59 years (P = .06). HPV vaccine types 6 and 11 (low-risk types) and 16 and 18 (high-risk types) were detected in 3.4% of female participants; HPV-6 was detected in 1.3% (95% CI, 0.8%-2.3%), HPV-11 in 0.1% (95% CI, 0.03%-0.3%), HPV-16 in 1.5% (95% CI, 0.9%-2.6%), and HPV-18 in 0.8% (95% CI, 0.4%-1.5%) of female participants. Independent risk factors for HPV detection were age, marital status, and increasing numbers of lifetime and recent sex partners. CONCLUSIONS: HPV is common among females in the United States. Our data indicate that the burden of prevalent HPV infection among females was greater than previous estimates and was highest among those aged 20 to 24 years. However, the prevalence of HPV vaccine types was relatively low.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Casella, G., & Berger, R. (2024) · Chapman & Hall/CRC eBooks · doi:10.1201/9781003456285 · Cited by 5,711
Le, M. (2007) · Medical Entomology and Zoology · Cited by 1,624
A Controlled Trial of a Human Papillomavirus Type 16 Vaccine
Koutsky, L. A., Ault, K. A., Wheeler, C. M., Brown, D. R., Barr, E., Alvarez, F. B., Chiacchierini, L. M., & Jansen, K. U. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020586 · Cited by 1,602
Villa, L. L., Costa, R. L., Petta, C. A., Andrade, R. P., Ault, K. A., Giuliano, A. R., Wheeler, C. M., Koutsky, L. A., Malm, C., Lehtinen, M., et al. (2005) · The Lancet Oncology · doi:10.1016/s1470-2045(05)70101-7 · Cited by 1,579
Sexually Transmitted Diseases Among American Youth: Incidence and Prevalence Estimates, 2000
Weinstock, H., Berman, S., & Cates, W. (2004) · Perspectives on Sexual and Reproductive Health · doi:10.1363/3600604 · Cited by 1,258
Sexually Transmitted Diseases Among American Youth: Incidence and Prevalence Estimates, 2000
Weinstock, H., Berman, S., & Cates, W. (2004) · Perspectives on Sexual and Reproductive Health · doi:10.1111/j.1931-2393.2004.tb00002.x · Cited by 1,153
Improved Amplification of Genital Human Papillomaviruses
Gravitt, P. E., Peyton, C. L., Alessi, T. Q., Wheeler, C. M., Coutlée, F., Hildesheim, A., Schiffman, M. H., Scott, D. R., & Apple, R. J. (2000) · Journal of Clinical Microbiology · doi:10.1128/jcm.38.1.357-361.2000 · Cited by 1,137 · cited 1×
“This assay uses HPV L1 consensus polymerase chain reaction with biotinylated PGMY09/11 primer sets and -globin as an internal control for sample amplification.(18,19) Five μL of the DNA was used in the 100-μL polymerase chain reaction.”
MethodWiner, R. L. (2003) · American Journal of Epidemiology · doi:10.1093/aje/kwf180 · Cited by 1,044
Korn, E. L., & Graubard, B. I. (1999) · Wiley eBooks · doi:10.1002/9781118032619 · Cited by 1,044
Trends in Herpes Simplex Virus Type 1 and Type 2 Seroprevalence in the United States
Xu, F., Sternberg, M. R., Kottiri, B. J., McQuillan, G. M., Lee, F. K., Nahmias, A. J., Berman, S. M., & Markowitz, L. E. (2006) · JAMA · doi:10.1001/jama.296.8.964 · Cited by 1,035
Self-citation(2001) · Technometrics · doi:10.1198/tech.2001.s612 · Cited by 989
Chapter 1: Human Papillomavirus and Cervical Cancer--Burden and Assessment of Causality
Bosch, F. X., & de Sanjose, S. (2003) · JNCI Monographs · doi:10.1093/oxfordjournals.jncimonographs.a003479 · Cited by 826
Design and estimation for the National Health Interview Survey, 1995-2004
Botman, S., & Moriarity, C. L. (2000) · Cited by 785
The epidemiology of genital human papillomavirus infection
Trottier, H., & Franco, E. L. (2006) · Vaccine · doi:10.1016/j.vaccine.2005.09.054 · Cited by 686
Franco, E. L., Villa, L. L., Sobrinho, J. P., Prado, J. M., Rousseau, M., Désy, M., & Rohan, T. E. (1999) · The Journal of Infectious Diseases · doi:10.1086/315086 · Cited by 657
Gravitt, P. E., Peyton, C. L., Apple, R. J., & Wheeler, C. M. (1998) · Journal of Clinical Microbiology · doi:10.1128/jcm.36.10.3020-3027.1998 · Cited by 646
Moscicki, A.-B., Shiboski, S., Broering, J., Powell, K., Clayton, L., Jay, N., Darragh, T. M., Brescia, R., Kanowitz, S., Miller, S. B., et al. (1998) · The Journal of Pediatrics · doi:10.1016/s0022-3476(98)70445-7 · Cited by 564
Sellors, J. W., Lorincz, A. T., Mahony, J. B., Mielzynska, I., Lytwyn, A., Roth, P., Howard, M., Chong, S., Daya, D., Chapman, W. B., et al. (2000) · Europe PMC (PubMed Central) · Cited by 256
Determinants of Genital Human Papillomavirus Detection in a US Population
Peyton, C. L., Gravitt, P. E., Hunt, W. C., Hundley, R. S., Zhao, M., Apple, R. J., & Wheeler, C. M. (2001) · The Journal of Infectious Diseases · doi:10.1086/320696 · Cited by 252
Seroprevalence of Human Papillomavirus Type 16 Infection in the United States
Stone, K. M., Karem, K. L., Sternberg, M. R., McQuillan, G. M., Poon, A. D., Unger, E. R., & Reeves, W. C. (2002) · The Journal of Infectious Diseases · doi:10.1086/344354 · Cited by 222
Self-citationAndersen, E. B. (1990) · The Statistical Analysis of Categorical Data · doi:10.1007/978-3-642-97225-6_3 · Cited by 214
(2006) · The Journal of Pathology · doi:10.1002/(issn)1096-9896 · Cited by 213
Dzuba, I. G., Díaz, E. Y., Allen, B., Leonard, Y. F., Lazcano Ponce, E. C., Shah, K. V., Bishai, D., Lorincz, A., Ferris, D., Turnbull, B., et al. (2002) · Journal of Women's Health & Gender-Based Medicine · doi:10.1089/152460902753668466 · Cited by 208
Ogilvie, G. S. (2005) · Sexually Transmitted Infections · doi:10.1136/sti.2004.011858 · Cited by 182
Manhart, L. E., Holmes, K. K., Koutsky, L. A., Wood, T., Kenney, D. L., Feng, Q., & Kiviat, N. B. (2006) · Sexually Transmitted Diseases · doi:10.1097/01.olq.0000204545.89516.0a · Cited by 156
Vernon, S. D., Unger, E. R., & Williams, D. (2000) · Journal of Clinical Microbiology · doi:10.1128/jcm.38.2.651-655.2000 · Cited by 141 · cited 1×
“Samples that did not hybridize the strip were sequenced as previously described to determine HPV type.(21) Samples negative for both -globin and HPV (n=105, 5.”
MethodSelf-citationHuman papillomavirus in a necessary cause of invasive cervical cancer worldwide
(1999) · Pure Amsterdam UMC · doi:10.1002/(sici)1096-9896(199909)189:1 · Cited by 140
Tarkowski, T. A., Koumans, E. H. A., Sawyer, M. K., Pierce, A., Black, C. M., Papp, J. R., Markowitz, L. E., & Unger, E. R. (2004) · The Journal of Infectious Diseases · doi:10.1086/380466 · Cited by 140
Self-citationGravitt, P. E., Lacey, J. V., Brinton, L. A., Barnes, W. A., Kornegay, J., Greenberg, M., Greene, S. M., Hadjimichael, O. C., McGowan, L., Mortel, R., et al. (2001) · PubMed · Cited by 139
A Population‐Based Study of Vaginal Human Papillomavirus Infection in Hysterectomized Women
Castle, P. E., SCHIFFMAN, M. H., Bratti, M. C., Hildesheim, A., Herrero, R., Hutchinson, M. L., Rodríguez, A. C., Wacholder, S., Sherman, M. E., Kendall, H., et al. (2004) · The Journal of Infectious Diseases · doi:10.1086/421916 · Cited by 77
SUDAAN User's Manual, Release 9.0
Witt, M., & Barnwell, B. (2004) · Cited by 76
Lorenzato, F. R. B., Singer, A., Ho, L., Santos, L. C., Batista, R. D. L., Costa, T. M. L., & Terry, G. (2002) · American Journal of Obstetrics and Gynecology · doi:10.1067/mob.2002.122390 · Cited by 60
Acceptability of human papillomavirus self testing in female adolescents
Kahn, J. A., Bernstein, D. I., Rosenthal, S. L., Huang, B., Kollar, L. M., Colyer, J. L., Tissot, A. M., Hillard, P. A., Witte, D., Groen, P., et al. (2005) · Sexually Transmitted Infections · doi:10.1136/sti.2004.012047 · Cited by 59
Comparison of type-specific human papillomavirus data from self and clinician directed sampling
Baldwin, S. B., Santos, C., de Galaz, E. M. B., Nuño, T., Giuliano, A. R., Davis, J. R., & García, F. (2005) · Gynecologic Oncology · doi:10.1016/j.ygyno.2005.02.001 · Cited by 35
Cited by
Human papillomavirus and cervical cancer
Schiffman, M., Castle, P. E., Jeronimo, J., Rodriguez, A. C., & Wacholder, S. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61416-0 · Cited by 2,985
Human papillomavirus and cervical cancer
Burd, E. M. (2003) · Clinical Microbiology Reviews · doi:10.1128/cmr.16.1.1-17.2003 · Cited by 2,420
Paavonen, J., Naud, P., Salmerón, J., Wheeler, C., Chow, S.-N., Apter, D., Kitchener, H., Castellsague, X., Teixeira, J., Skinner, Sr., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61248-4 · Cited by 1,655
Saslow, D., Solomon, D., Lawson, H. W., Killackey, M., Kulasingam, S. L., Cain, J., Garcia, F. A. R., Moriarty, A. T., Waxman, A. G., Wilbur, D. C., et al. (2012) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21139 · Cited by 1,390
Human papillomavirus and cervical cancer
Crosbie, E. J., Einstein, M. H., Franceschi, S., & Kitchener, H. C. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60022-7 · Cited by 1,171
Metadata
- Authors
- Dunne, E. F., Unger, E. R., Sternberg, M., McQuillan, G., Swan, D. C., Patel, S. S., & Markowitz, L. E.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2007-02-28
- Volume
- 297
- Issue
- 8
- Pages
- 813
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2125058204
- Cited by
- 1,579
- References
- 34
- FWCI
- 89.40
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.